This content is from: Home

UK’s patent incentive leads to GSK investment

GlaxoSmithKline will invest more than £500 million in the UK, after the government confirmed it would provide a tax incentive for patents

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial